Subscribe to Updates
Get the latest creative news from FooBar about art, design and business.
Author: healthadmin
worldwide annual production Plastic usage is predicted to increase to 400 million tonnes in 2022 and double by 2050. Many of the products produced are used once and then thrown away, with more than 30 billion plastic bottles sold each year in the United States alone. Less than 10% of plastic waste is recycled. It is clear that the problem of plastic pollution in terrestrial and marine environments is not going away. This series includes research into the increasing demand for single-use bottled water and considers several approaches to addressing it.According to an industry survey released in 2024, a whopping…
Eli Lilly is setting up a huge manufacturing facility in Houston, but it’s not the only big U.S. drug company eyeing the populous Texas town. Bristol-Myers Squibb is considering building a $1 billion manufacturing facility in Houston that would employ nearly 500 people, according to a filing (PDF) with the state. If the project goes ahead, Bristol will initially build a 600,000-square-foot factory with the possibility of expansion in the future. The company will be located in the Generation Park Management District on the city’s northeast side and will produce pharmaceuticals for domestic and international markets, according to the filing.…
First, AstraZeneca’s Enhertz receives double FDA approval to treat early-stage breast cancer
Enhertu’s market conquest continues apace. Daiichi Sankyo and AstraZeneca’s star antibody-drug conjugate, which already has annual sales of $5 billion, has secured FDA approval as a treatment for early-stage breast cancer, further encroaching on the territory of Roche’s Kadcyla. The FDA has simultaneously given Enhertu the go-ahead for both neoadjuvant and postoperative therapy in patients with HER2-positive early-stage breast cancer, the companies announced Friday. The FDA originally aimed to make a decision by July 7, so the adjuvant treatment agreement came nearly two months ahead of schedule. Although early, there are pitfalls with adjuvant labels. Patients who receive Enhertz preoperatively…
Scientists opened the sealed envelope 10 years later, but gravity still didn’t make sense
For more than two centuries, scientists have been trying to determine one of the most important numbers in physics: the universal gravitational constant, known as the “big.” GThis defines the strength of gravity throughout the universe, affecting everything from falling objects on Earth to the motion of galaxies. However, despite its importance, researchers still cannot agree on its exact value. That uncertainty weighed heavily on National Institute of Standards and Technology physicist Stephen Schlamminger as he prepared to open a sealed envelope containing an important secret number. For nearly a decade, Schlamminger has devoted much of his career to large…
In a large phase 3 clinical trial presented at the 2026 ATS International Conference, one oral tablet taken nightly helped control obstructive sleep apnea. The drug, called AD109, is the first therapy to treat OSA by addressing the underlying mechanisms of OSA and targeting the neuromuscular causes of airway collapse. “Aroxybutynin and atomoxetine (AD109) for obstructive sleep apnea syndrome: A randomized phase 3 trial” will be published in the American Journal of Respiratory and Critical Care Medicine. The trial, called SynAIRgy, showed that patients who took AD109 had fewer breathing interruptions during sleep, less oxygen deprivation, and improved overall blood…
Surgical training program for community health workers reduces maternal mortality risk
Sierra Leone’s maternal mortality rate was once among the highest in the world. A 15-year nonprofit program that trains community health workers to perform life-saving surgeries has helped cut that risk by two-thirds. Fourteen years ago, Haakon Volkan, a surgeon at the Norwegian University of Science and Technology (NTNU), predicted a new training program he and his colleagues were starting to expand access to surgery in the West African country of Sierra Leone. I believe that if this program continues for several years,[its graduates]will become the core of surgical care in regional hospitals in Sierra Leone. ” Haakon…
Brainwave monitoring reveals how psychopathic traits destroy trust and reward in social scenarios
People who score high on psychopathic traits are less likely to trust strangers and show distinct brain activity when evaluating social risks and economic rewards. Experiments using electroencephalographic recordings suggest that these individuals experience intense cognitive conflict when inhibiting cooperative behavior and feel great disappointment when their expectations for payment are violated. The study was published in the journal BMC Psychology. While popular media often depicts psychopathy as a characteristic unique to violent criminals, psychologists recognize it as a continuous spectrum that exists in the general population. Characteristics of psychopaths include being manipulative, lacking empathy, selfishness, and impulsivity. Because these…
Explore eleven pivotal clinical trials and breakthroughs in gene editing, oncology, and regenerative medicine set to redefine healthcare standards in 2026.
One of cruise passengers’ biggest fears is the spread of infectious diseases at sea. Two Texans were recently on a cruise ship, and 147 passengers and crew members may have been infected with hantavirus. Hantaviruses are serious and potentially fatal respiratory viruses that originate from rodent feces. The outbreak was reported to the World Health Organization on May 2, 2026, and the disease was quickly identified as an Andean strain of hantavirus. In the United States, hantavirus infections are rare, with fewer than 900 cases reported between 1993 and 2023. When infections occur in the United States, they usually cause…
Butyrate, a metabolite of gut microbiota, reduces chronic temporomandibular joint pain
Temporomandibular joint (TMJ) pain is associated with disruption of gut microbiota metabolites. Researchers have shown that butyrate, administered as tributyrin, reduces pain by restoring histone acetylation and reversing changes in gene regulation in the brain. The research team identified key genes involved in pain regulation, including: No.14 We use a mouse model and single-cell multi-omics sequencing. Targeting the butyrate-related epigenetic pathway may provide a promising non-opioid strategy for the treatment of temporomandibular joint pain. Temporomandibular joint disorders are a major cause of chronic orofacial pain and often result from a complex interaction between neurological, inflammatory, and systemic factors. However, current…